This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Bacillus anthracis Protective Antigen (pagA), N-His
Product Overview
BioVenic's Recombinant Bacillus anthracis Protective Antigen (pagA), N-His is a recombinant protein expressed from E.coli. Its predicted molecular weight is 89.1 kDa. The purity is>90% (SDS-PAGE).
Specifications
Target Information
Bacillus anthracis Protective antigen (pagA) is a key component of the anthrax toxin, facilitating the binding of the toxin to host cells and the translocation of its enzymatic components, edema factor, and lethal factor. In veterinary medicine, pagA is crucial for understanding the pathogenesis of anthrax and for the development of vaccines and therapeutics targeting the toxin's activity, thereby protecting animals from anthrax infection.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store at -20°C/-80°C upon receipt, aliquoting is necessary for mutiple use.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.